The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...

Traumatic injury to the brain, spinal cord and optic nerve in the central nervous system (CNS) are the leading cause of disability and the second leading cause of death worldwide. CNS injuries often ...

U.S. biotech firm Life Biosciences announced on the 9th (local time) that it has begun the first human clinical trial ...

Traumatic injury to the brain, spinal cord and optic nerve in the central nervous system (CNS) are the leading cause of disability and the second leading cause of death worldwide. CNS injuries often ...

TORONTO and HAIFA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company ...

Oculis is a proud sponsor of Clinical Trials at the Summit 2026, which brings together experts from around the world to discuss ongoing clinical trials and the latest data, all with the goal of ...

Optic atrophy is a condition in which the optic nerve begins to deteriorate. The optic nerve is the nerve at the back of your eye that connects your eye to your brain, allowing you to see. There are a ...

What Is Optic Nerve Drusen? Optic nerve drusen is a rare eye condition that affects between 3 and 24 people out of every 1,000 in the population. It’s difficult to estimate exactly how common this ...

An optic nerve glioma is a type of noncancerous, slow-growing tumor that develops in the glial cells of the optic nerve. They are most common in children. Doctors may refer to this type of tumor as ...